Module 3 - Skin & Soft Tissue Lesions

Melanoma


Pre-malignant Lesions:

A. Dysplastic nevi

Nevus with irregular borders

  • ABCD’s of dysplastic nevi:

Nevus with multiple colors

  • Asymmetry
  • Border irregularity
  • Colour variegation (tan to brown on pink base)
  • Diameter is large (5-12 mm)
  • Macular and papular components

B. Congenital nevi (aka. Birthmarks)

  • Large birthmarks (>20 cm) have an increased risk of developing into melanoma.
  • Nevus with multiple colors

Asymetric Nevus


Malignant Lesions:

A. Superficial spreading melanoma

Superficial spreading melanoma 

  • Most common form (70% of melanomas)
  • A flat or elevated brown lesion that develops black, blue, red or white pigments; combination of coloured nodules is a hallmark of this melanoma
  • Slow growing with lateral spread and irregular borders
  • Most often on the upper back of men and women and lower extremities of women
  • 50% arise from pre-existing nevi


B. Nodular melanoma

Nodular Melanoma


  • Most aggressive form, deeply invading the dermis and subcutaneous tissue
  • Rapidly becomes a palpable, elevated, and firm nodule
  • Most often seen in elderly and male population; found on any region of the body
  • Dark brown, red-brown, or red-black; 5% are flesh coloured (amelanotic)
  • Dome-shaped, polypoid, or pedunculated; can ulcerate and bleed
  • Most frequently misdiagnosed melanoma because of its similarity to hemagiomas, blood blisters, dermal nevus, seborrheic keratosis, or dermatofibroma.


C. Lentigo maligna melanoma (LMM)

  • Large melanotic freckle (3-6 cm) usually found in elderly patients in temple or malar region
  • Brown to black macular pigmentation with raised blue to black nodules
  • Begins with a radial growth phase known as lentigo maligna (LM) or Hutchinson’s freckle, however less than 10% of LM cases become LMM
  • Slow growing (5-20 yrs) and initially flat, becoming elevated and thick


D. Acral Lentiginous Melanoma

Acral Lentiginous Melanoma

  • Occurs primarily in dark-pigmented people
  • 30-75% of melanomas affecting African Americans, Asians, and Hispanics
  • Clinical presentation of lesion similar to LM or LMM
  • Found on palms, soles, nail beds and mucous membranes
  • Very aggressive melanoma with a higher frequency of metastases


Risk Factors:

  • Family or personal history of melanoma
  • Blond or red hair
  • Freckling of the upper back
  • Three or more blistering sunburns before age 20 (UVA/UVB)
  • Presence of actinic keratosis
  • Blue, green or grey eyes

* Having 3 or more of these increases risk 20-fold:

* 1/3 of melanomas arise from pigmented nevi; ABCD

 

Staging and Prognosis

  • Clark levels examine the depth of tumour invasion based on epidermal, dermal and subcutaneous tissue invasion.
  • Breslow levels measure the depth of tumour invasion in millimetres and is the preferred method as it is considered more accurate.
  • Metastatic lesions in the skin, known as satellites, within 2 cm of the 1o tumour signify poor prognosis with high risk of local recurrence and distant metastasis
  • In-transit metastases, noted as metastatic lesions >2 cm away from the 1o tumour, arise from tumour cells in intradermal lymphatics and also signify poor prognosis


Treatment

A. Surgery

  • Wide local excision
  • Thin melanomas (<1 mm) should have margin of 1 cm
  • Thicker and scalp lesions should have margin of 2 cm
  • Finger and toes require amputation
  • Sentinel Lymph Node Biopsy (SLN) for lesions ≥ 1 mm in depth
  • Regional Lymph Node Dissection if sentinel lymph node biopsy is positive
  • Resection of metastases

 B. Adjuvant therapies (limited effectiveness observed):

  • IFN-alpha2b; IL-2
  • BCG
  • Vaccines
  • Chemotherapy:  DTIC, BCNU, cisplatin, tamoxifen, vincristine
  • Radiotherapy

Author: SP Zinn